Sidebar Ads

Monday, December 10, 2018

Gilead Sciences snares Roche veteran O'Day as CEO

Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG's Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.


from Reuters: Business News https://ift.tt/2EfDHlV

Related Posts:

0 comments:

Post a Comment

Oasis sale 'may have misled fans' says watchdog

CMA concerned that Ticketmaster may have breached consumer protection law for Oasis reunion tour. from BBC News https://ift.tt/POxCk3r